- September 3, 2022
- Newsletter
- 617-430-5616
Menu
» Home » CAD » Endocrinology » Diabetes Mellitus » Hypoglycemia
ADVERTISEMENT
ADVERTISEMENT
» Home » CAD » Endocrinology » Diabetes Mellitus » Hypoglycemia
Background
Epidemiology
Anatomy
Pathophysiology
Etiology
Genetics
Prognostic Factors
Clinical History
Physical Examination
Age group
Associated comorbidity
Associated activity
Acuity of presentation
Differential Diagnoses
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
by Stage
by Modality
Chemotherapy
Radiation Therapy
Surgical Interventions
Hormone Therapy
Immunotherapy
Hyperthermia
Photodynamic Therapy
Stem Cell Transplant
Targeted Therapy
Palliative Care
Medication
200 mcg orally every day
Administer 10 to 25 g intravenously
Take 4 to 20 g orally as a one-time dosage and can be administered again after 15 minutes if personal blood glucose monitoring indicates persistent low blood sugar levels
The initial oral dosage is 3 mg/kg daily, divided into doses every 8 to 12 hours
Typically, the dose range is between 3 to 8 mg/kg each day
Individuals experiencing refractory hypoglycemia might necessitate elevated dosage levels
instant glucose/intravenous dextrose
Administer dose of 10 to 25 g intravenously
Take 15 to 20 g orally as a single dose and repeat again in 15 minutes if self-monitoring of blood glucose (SMBG) showing continuous hypoglycemia
Glucose tolerance test
One step:
Take 75 g orally as single dose to a fasting patient
Evaluate plasma glucose levels two hours after administration in nonpregnant individuals or one and two hours after administration in pregnant females
For Pregnant women:
First step:
Take 50 g orally as a single dose to a non-fasting patient
Evaluate plasma glucose levels one hour after administration, if levels are equal to or greater than 130 mg/dl, continue with the 100 g oral glucose tolerance test
Second step:
Take 100 g orally as a single dose to a fasting patient
Evaluate plasma glucose levels at one, two, and three hours after dose
200 mcg orally every day
For less than 6 months:
0.25 to 0.5 g/kg/dose intravenously and maximum limit of 25 g for one dose.
For Infants more than 6 months and children:
0.5 to 1 g/kg/dose intravenously and maximum limit of 25 g for one dose
For adolescents:
Administer 10 to 25 g intravenously
Take 4 to 20 g orally as a one-time dosage and can be administered again after 15 minutes if personal blood glucose monitoring indicates persistent low blood sugar levels
Neonate/infant: Initially, 10 mg/kg orally daily divided every 8 hours
Typical dose ranges from 8-15 mg/kg orally daily divided every 8-12 hours
Children: initially 3 mg/kg orally divided every 8 hours
typical dose range is from 3-8 mg/kg orally daily divided every 8-12 hours
instant glucose/intravenous dextrose
For Infants and Children (Dextrose 25% solution)
Administer dose of 0.5 to 1 g/kg intravenously and Intraosseous
Maximum dose not more than 25 g
For Adolescents (Dextrose 50% solutions):
Administer dose of 0.5 to 1 g/kg intravenously and Intraosseous
Maximum dose not more than 25 g
For Children and Adolescents:
Take dose of 0.3 g/kg orally as a single dose
Maximum dose not more than 15 to 20 g
Future Trends
References
ADVERTISEMENT
» Home » CAD » Endocrinology » Diabetes Mellitus » Hypoglycemia
200 mcg orally every day
Administer 10 to 25 g intravenously
Take 4 to 20 g orally as a one-time dosage and can be administered again after 15 minutes if personal blood glucose monitoring indicates persistent low blood sugar levels
The initial oral dosage is 3 mg/kg daily, divided into doses every 8 to 12 hours
Typically, the dose range is between 3 to 8 mg/kg each day
Individuals experiencing refractory hypoglycemia might necessitate elevated dosage levels
instant glucose/intravenous dextrose
Administer dose of 10 to 25 g intravenously
Take 15 to 20 g orally as a single dose and repeat again in 15 minutes if self-monitoring of blood glucose (SMBG) showing continuous hypoglycemia
Glucose tolerance test
One step:
Take 75 g orally as single dose to a fasting patient
Evaluate plasma glucose levels two hours after administration in nonpregnant individuals or one and two hours after administration in pregnant females
For Pregnant women:
First step:
Take 50 g orally as a single dose to a non-fasting patient
Evaluate plasma glucose levels one hour after administration, if levels are equal to or greater than 130 mg/dl, continue with the 100 g oral glucose tolerance test
Second step:
Take 100 g orally as a single dose to a fasting patient
Evaluate plasma glucose levels at one, two, and three hours after dose
200 mcg orally every day
For less than 6 months:
0.25 to 0.5 g/kg/dose intravenously and maximum limit of 25 g for one dose.
For Infants more than 6 months and children:
0.5 to 1 g/kg/dose intravenously and maximum limit of 25 g for one dose
For adolescents:
Administer 10 to 25 g intravenously
Take 4 to 20 g orally as a one-time dosage and can be administered again after 15 minutes if personal blood glucose monitoring indicates persistent low blood sugar levels
Neonate/infant: Initially, 10 mg/kg orally daily divided every 8 hours
Typical dose ranges from 8-15 mg/kg orally daily divided every 8-12 hours
Children: initially 3 mg/kg orally divided every 8 hours
typical dose range is from 3-8 mg/kg orally daily divided every 8-12 hours
instant glucose/intravenous dextrose
For Infants and Children (Dextrose 25% solution)
Administer dose of 0.5 to 1 g/kg intravenously and Intraosseous
Maximum dose not more than 25 g
For Adolescents (Dextrose 50% solutions):
Administer dose of 0.5 to 1 g/kg intravenously and Intraosseous
Maximum dose not more than 25 g
For Children and Adolescents:
Take dose of 0.3 g/kg orally as a single dose
Maximum dose not more than 15 to 20 g
Founded in 2014, medtigo is committed to providing high-quality, friendly physicians, transparent pricing, and a focus on building relationships and a lifestyle brand for medical professionals nationwide.
USA – BOSTON
60 Roberts Drive, Suite 313
North Adams, MA 01247
INDIA – PUNE
7, Shree Krishna, 2nd Floor, Opp Kiosk Koffee, Shirole Lane, Off FC Road, Pune 411004, Maharashtra
Founded in 2014, medtigo is committed to providing high-quality, friendly physicians, transparent pricing, and a focus on building relationships and a lifestyle brand for medical professionals nationwide.
MASSACHUSETTS – USA
60 Roberts Drive, Suite 313,
North Adams, MA 01247
MAHARASHTRA – INDIA
7, Shree Krishna, 2nd Floor,
Opp Kiosk Koffee,
Shirole Lane, Off FC Road,
Pune 411004, Maharashtra
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.